<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04323865</url>
  </required_header>
  <id_info>
    <org_study_id>fHRV_1</org_study_id>
    <nct_id>NCT04323865</nct_id>
  </id_info>
  <brief_title>Fetal Heart Rate Variability</brief_title>
  <official_title>Non-invasive Fetal Electrocardiography (NI-FECG); Repeatability of Time-domain and Spectral Analyses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Br√∏drene Hartmanns Fond</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Augustinus Fonden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Dagmar Marshall Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AP Moeller Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Need statement

      - a new way to distinguish between a healthy small fetus and a small fetus suffering from
      deprivation of nutrition and oxygen to prevent unnecessary induction of preterm birth and
      improve neonatal outcome.

      Aim - to characterize fetal heart rate variability (fHRV) based on fetal ECG in the normal
      fetus and in the fetus suffering from growth retardation to evaluate its value and
      applicability as a supplementary tool in fetal surveillance.

      Aim of current study

      - To evaluate the feasibility of NI-FECG from gestational week 20 and onwards and investigate
      if important factors as length and heart rate pattern affects repeatability of time domain
      and spectral analyses in fetuses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">February 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Standard deviation of normal to normal RR-interval (SDNN)</measure>
    <time_frame>01.04.2020</time_frame>
    <description>Time domain analysis, measured in ms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Root mean square of successive RR-interval differences (RMSSD)</measure>
    <time_frame>01.04.2020</time_frame>
    <description>Time domain analysis, measured in ms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low frequency power (LF-power)</measure>
    <time_frame>01.04.2020</time_frame>
    <description>Spectral analysis, measured in ms^2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>High frequency power (HF-power)</measure>
    <time_frame>01.04.2020</time_frame>
    <description>Spectral analysis, measured in ms^2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LF-power/HF-power</measure>
    <time_frame>01.04.2020</time_frame>
    <description>Spectral analysis, ratio</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Fetal Growth Retardation</condition>
  <arm_group>
    <arm_group_label>Study 2. Repeatability of FHRV</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>fetal heart rate variability</intervention_name>
    <description>No direct intervention, as the study is observational.</description>
    <arm_group_label>Study 2. Repeatability of FHRV</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Danish. Healthy. Pregnant women. Expecting a healthy fetus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy singleton pregnancies

        Exclusion Criteria:

          -  fetal malformations, multiple pregnancy, obstetric complications, maternal chronic
             disease and labor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arhus Universityhospital</name>
      <address>
        <city>Aarhus</city>
        <state>Aarhus N</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

